Clinical Trial Update: The Efficacy and Safety of Iguratimod (IGU) in the Treatment of Primary Sjögren's Syndrome [Phase 4]

View source ↗

Summary

This clinical trial update notes a Phase 4 study evaluating the efficacy and safety of iguratimod for Primary Sjögren's Syndrome, currently in recruitment with …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Sjögren Syndrome

Drugs mentioned

• Iguratimod (iguratimod)

Snippet

Sponsor: Second Affiliated Hospital, School of Medicine, Zhejiang University | Conditions: Primary Sjögren's Syndrome | Phase 4 | Status: RECRUITING